Latest Breaking News On - Glaxosmithkline pharmaceuticals - Page 1 : comparemela.com

How companies are tweaking ESG disclosures selectively

The Environment, Social and Governance (ESG) disclosures as mandated by SEBI is still in the nascent stage in India but an assessment of the last three years' submissions by corporates found that companies are tweaking them on their own.

Anti-infectives Market Size, Trends and Future Scope Forecast 2023-2033

Anti-infectives Market: by Product (Antibiotics, Antivirals, Antifungals, Others), by Indication (HIV Infection, Pneumonia, Respiratory Virus Infection, Sepsis, Tuberculosis, Others), by Route Of Administration (Oral, Topical, Parenteral, Others), by

GlaxoSmithKline Consolidated March 2024 Net Sales at Rs 929.80 crore, up 18.08% Y-o-Y

Glaxosmithkline Pharmaceuticals Q4 Results Live : profit rise by 45.76% YOY

Glaxosmithkline Pharmaceuticals Q4 Results Live : Revenue increased by 18.08% YoY & profit increased by 45.76% YoY

Stocks that will see action today: March 17, 2024 - The Hindu BusinessLine